Towards Healthcare
Drug Discovery Market to Surge USD 160.11 Bn by 2034

Drug Discovery Market Advances with Computational Tools

Projections indicate that, the global drug discovery market will increase from USD 65.88 billion in 2024 to USD 160.11 billion by 2034, experiencing a CAGR of 9.24% over the next 10 years. The rising prevalence of chronic disorders and technological advancements bolster market growth. North America dominated the global market owing to the presence of key players and increasing investments.

Content

  • Insight Code: 6217
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The drug discovery market is valued at USD 71.96 billion in 2025 and is on track to reach USD 160.11 billion by 2034, witnessing a steady CAGR of 9.24% during the forecast span.

North America is leading the drug discovery market due to the availability of state-of-the-art research and development facilities, technological advancements, and favorable regulatory policies.

Some key players include Charles River Laboratories, Novartis, and Thermo Fisher Scientific.

Drug development is categorized into 4 phases, including discovery, preclinical studies, clinical development, and market approval.

World Health Organization, Food and Drug Administration, National Institute of Health, Government of Canada
Any Questions